Why the study?
Does reperfusion therapy (thrombolytic or mechanical) improve outcomes in patients with acute myocardial infarction with ST-segment elevation?
Does reperfusion therapy (thrombolytic or mechanical) improve outcomes in patients with acute myocardial infarction with ST-segment elevation?
This review outlines the advantages and limitations of medical versus mechanical reperfusion therapies for ST-segment elevation myocardial infarction.
Answers are grounded in this paper and cite their sources.
Supports individualized STEMI reperfusion decisions; leaves open optimal strategy selection in contemporary practice.
Coronary arterial occlusion due to thrombosis is the cause of most cases of myocardial infarction accompanied by ST-segment elevation. Rapid restoration of blood flow to jeopardized myocardium limits necrosis and reduces mortality. This can be accomplished medically, with a thrombolytic agent, or mechanically, with so-called primary balloon angioplasty or stenting (see figure). Each method has its advantages and limitations.Thrombolytic therapy is widely available and effective, but its use is sometimes associated with bleeding complications. In 10 to 15 percent of patients who receive a thrombolytic agent, clot lysis is not achieved. Only half the patients in whom antegrade coronary . . .
No takes yet. Share an insight, caveat, or question.
Lange et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: